• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊精神科医生开具抗抑郁药的处方趋势。

Trends in the prescription of antidepressants by office-based psychiatrists.

作者信息

Olfson M, Klerman G L

机构信息

Department of Psychiatry, Cornell University Medical College, New York, NY.

出版信息

Am J Psychiatry. 1993 Apr;150(4):571-7. doi: 10.1176/ajp.150.4.571.

DOI:10.1176/ajp.150.4.571
PMID:8465872
Abstract

OBJECTIVE

This study was done in an effort to determine whether there was a change over the past decade in the number and proportion of patients prescribed antidepressants by psychiatrists in private practice.

METHOD

The authors analyzed data from the National Ambulatory Medical Care Survey for the years 1980, 1985, and 1989, focusing on visits by adults over the age of 18 years to physicians specializing in psychiatry and psychiatric subspecialties.

RESULTS

The number of visits that included prescribing an antidepressant medication grew from approximately 2.5 million in 1980 to 4.7 million in 1989, or from 17.9% to 30.4% of all office-based psychiatric visits. Fluoxetine, which first became available in 1988, accounted for 29.6% of the prescriptions for antidepressants in 1989. Increases in prescriptions for antidepressants were particularly evident for male patients, young adult patients, and patients with neurotic disorders.

CONCLUSIONS

There was an increase in the 1980s in the use of antidepressants in office-based psychiatric practice. The advent of new agents and the broadening of the clinical usefulness of existing agents may have contributed to this increase.

摘要

目的

本研究旨在确定在过去十年中,私人执业精神科医生开具抗抑郁药的患者数量及比例是否发生了变化。

方法

作者分析了1980年、1985年和1989年全国门诊医疗护理调查的数据,重点关注18岁以上成年人到精神科专科医生及精神科亚专科医生处就诊的情况。

结果

开具抗抑郁药处方的就诊次数从1980年的约250万次增加到1989年的470万次,占所有门诊精神科就诊次数的比例从17.9%增至30.4%。1988年首次上市的氟西汀在1989年的抗抑郁药处方中占29.6%。抗抑郁药处方的增加在男性患者、年轻成年患者和神经症患者中尤为明显。

结论

20世纪80年代,门诊精神科实践中抗抑郁药的使用有所增加。新药物的出现以及现有药物临床应用范围的扩大可能促成了这一增长。

相似文献

1
Trends in the prescription of antidepressants by office-based psychiatrists.门诊精神科医生开具抗抑郁药的处方趋势。
Am J Psychiatry. 1993 Apr;150(4):571-7. doi: 10.1176/ajp.150.4.571.
2
Antidepressant prescribing practices of outpatient psychiatrists.门诊精神科医生的抗抑郁药处方行为。
Arch Gen Psychiatry. 1998 Apr;55(4):310-6. doi: 10.1001/archpsyc.55.4.310.
3
National trends in psychotropic medication polypharmacy in office-based psychiatry.基于办公室的精神病学中精神药物联合用药的全国趋势。
Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.
4
The treatment of depression: prescribing practices of primary care physicians and psychiatrists.抑郁症的治疗:初级保健医生和精神科医生的处方实践。
J Fam Pract. 1992 Dec;35(6):627-35.
5
Trends in office-based psychiatric practice.基于办公室的精神科诊疗实践趋势。
Am J Psychiatry. 1999 Mar;156(3):451-7. doi: 10.1176/ajp.156.3.451.
6
Which factors influence psychiatrists' selection of antidepressants?哪些因素会影响精神科医生对抗抑郁药的选择?
Am J Psychiatry. 2004 Jul;161(7):1285-9. doi: 10.1176/appi.ajp.161.7.1285.
7
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.儿童和青少年使用抗精神病药物进行门诊治疗的全国趋势。
Arch Gen Psychiatry. 2006 Jun;63(6):679-85. doi: 10.1001/archpsyc.63.6.679.
8
Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.精神药物的处方趋势:初级保健、精神病学及其他医学专科。
JAMA. 1998 Feb 18;279(7):526-31. doi: 10.1001/jama.279.7.526.
9
Why isn't bupropion the most frequently prescribed antidepressant?为什么安非他酮不是最常被处方的抗抑郁药?
J Clin Psychiatry. 2005 May;66(5):603-10. doi: 10.4088/jcp.v66n0510.
10
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.

引用本文的文献

1
Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors.与单胺氧化酶抑制剂的临床相关药物相互作用
Health Psychol Res. 2022 Nov 3;10(4):39576. doi: 10.52965/001c.39576. eCollection 2022.
2
Prescribing practices in the treatment of depression among psychiatrists in Oman.阿曼精神科医生治疗抑郁症的处方实践。
Neurosciences (Riyadh). 2021 Apr;26(2):152-157. doi: 10.17712/nsj.2021.2.20200110.
3
Antidepressant use and diabetes mellitus risk: a meta-analysis.抗抑郁药的使用与糖尿病风险:一项荟萃分析。
Korean J Fam Med. 2013 Jul;34(4):228-40. doi: 10.4082/kjfm.2013.34.4.228. Epub 2013 Jul 24.
4
Comparative effectiveness of medication versus cognitive-behavioral therapy in a randomized controlled trial of low-income young minority women with depression.在一项针对低收入年轻少数族裔女性抑郁症的随机对照试验中,药物治疗与认知行为疗法的疗效比较。
J Consult Clin Psychol. 2012 Dec;80(6):995-1006. doi: 10.1037/a0030452. Epub 2012 Oct 22.
5
Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.血清素转运体基因(5-HTTLPR)、应激性生活事件与抑郁症风险之间的相互作用:一项荟萃分析。
JAMA. 2009 Jun 17;301(23):2462-71. doi: 10.1001/jama.2009.878.
6
A comparative survey of antidepressant drug prescribing habits of general practitioners and psychiatrists.一般执业医师和精神科医生抗抑郁药处方习惯的比较调查。
Clin Drug Investig. 1998;16(1):53-61. doi: 10.2165/00044011-199816010-00007.
7
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.使用贝叶斯净效益回归模型来检验仿制药进入对老年抑郁症患者中选择性5-羟色胺再摄取抑制剂成本效益的影响。
Pharmacoeconomics. 2007;25(10):843-62. doi: 10.2165/00019053-200725100-00004.
8
The role of monoamine oxidase inhibitors in current psychiatric practice.单胺氧化酶抑制剂在当前精神病学实践中的作用。
J Psychiatr Pract. 2004 Jul;10(4):239-48. doi: 10.1097/00131746-200407000-00005.
9
The economics of selective serotonin reuptake inhibitors in depression: a critical review.抑郁症中选择性5-羟色胺再摄取抑制剂的经济学:一项批判性综述。
CNS Drugs. 2001 Jan;15(1):59-83. doi: 10.2165/00023210-200115010-00005.
10
The need for an iterative process for assessing economic outcomes associated with SSRIs.需要一个迭代过程来评估与选择性5-羟色胺再摄取抑制剂(SSRI)相关的经济结果。
Pharmacoeconomics. 2000 Sep;18(3):205-14. doi: 10.2165/00019053-200018030-00001.